← Leaderboards
Daniel G. Panaccione
West Virginia University
$1,304,865
Attributed
$1,304,865
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $456K · FY2015–23$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,304,865 · 1
By mechanism
R15$1,304,865 · 1
Top collaborators
No co-investigators on record.
Most similar at West Virginia University
Same institution · by research overlap
- Chris None Baylis$7,483,914
Others in their field
Top investigators on “Hyperprolactinemia”
- Betty Diamond · Feinstein Institute For Medical Research$9,099,311
- Dipak Kumar Sarkar · Rutgers The St Univ Of Nj New Brunswick$5,039,153
- Shuk-Mei Ho · Central Arkansas Veterans Hlthcare Sys$2,833,500
- Marc Edward Freeman · Florida State University$2,622,898
- James D Shull · University Of Nebraska Medical Center$1,694,076
- Lydia A Arbogast · Southern Illinois University Carbondale$1,679,864
Research focus
HyperprolactinemiaGraduate StudentSenile DementiaFuturePathway InteractionsErgot AlkaloidsPharmacologic SubstanceS DiseaseMigraineUndergraduate StudentNon-Insulin-Dependent Diabetes MellitusFungusParkinson DiseaseAnabolismGenesModificationAlzheimer&AposDementiaGene ClusterAlkaloidsGene FunctionKnock-OutAcidsGene Product
Grant awards (4)
Strategic Reprogramming of the Ergot Alkaloid Pathway$86,388
R15 · FY2023 · GM · contact PI
Strategic Reprogramming of the Ergot Alkaloid Pathway$455,998
R15 · FY2022 · GM · contact PI
Strategic reprogramming of the ergot alkaloid pathway$429,534
R15 · FY2018 · GM · contact PI
Strategic reprogramming of the ergot alkaloid pathway$332,945
R15 · FY2015 · GM · contact PI